Quantitative accounting of CD34+ hematopoietic stem cells in whole cord blood

A. V. Kurtova , E. E. Zueva

Genes & Cells ›› : 66 -71.

PDF
Genes & Cells ›› :66 -71. DOI: 10.23868/gc126445
Original Study Articles
research-article

Quantitative accounting of CD34+ hematopoietic stem cells in whole cord blood

Author information +
History +
PDF

Abstract

Umbilical cord blood is an alternative source of hematopoietic stem cells to bone marrow and mobilized peripheral blood [HSC]. The population of CD34" cells in umbilical cord blood is small, which creates certain difficulties in carrying out quantitative accounting of HSC. This article discusses some practical aspects of determining CD34" HSC in whole cord blood. A preliminary assessment of the amount of HSC in the samples before the start of preparation for long-term storage may become an additional selection criterion when receiving cord blood in non-commercial anonymous banks.

Keywords

cord blood / CD34+ hematopoietic stem cells / flow cytometry

Cite this article

Download citation ▾
A. V. Kurtova, E. E. Zueva. Quantitative accounting of CD34+ hematopoietic stem cells in whole cord blood. Genes & Cells 66-71 DOI:10.23868/gc126445

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Watt S., Contreras М. Stem cell medicine: Umbilical cord blood and its stem cell potential. Semin. Fetal. Neonat. Med. 2005; 10: 209-20.

[2]

Bradley M.B., Cairo M.S. Cord blood immunology and stem cell transplantation. Human Immunol. 2005; 6: 431-46.

[3]

International Standards for Cord Blood Collection, Processing, Testing, Banking, Selection and Release. NETCORD/FACT 2006; 1-65.

[4]

Warwick R., Armitage S. Cord blood banking. Best Pract. Res. Clin. Obstet. Gynaecol. 2004; 18(6): 995-1011.

[5]

Gluckman E., Rocha V., Chastang C. Use of cord blood cells for banking and transplant. The Oncologist 1997; 2: 340-3.

[6]

Tse W„ Laughlin M.J. Umbilical cord blood transplantation: a new alternative option. Hematology Education Programme Book 2005; 377-83.

[7]

Nakagawa R., Watanabe T„ Kawano Y. et al. Analysis of maternal and neonatal factors that influence the nucleated and CD34+ cell yield for cord blood banking. Transfusion 2004; 44[2): 262-7.

[8]

Gratama J., Sutherland D.R., Keeney M„ Papa S. Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells. J. Biol. Regul. Homeost. Agents. 2001; 15:14-22.

[9]

Sutherland D.R., Anderson L, Keeney M. et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J. Hematother. 1996; 5:213-26.

[10]

Gutensohn K., Serke S., Cassens U. et al. German sociétés of hematology/oncology and transfusion medicine and immunohematology for flow cytometric CD34-determination. Infusionsther Transfusionmed. 1996; 23[suppl 2): 1-23.

[11]

Brocklebank A.M., Sparrow R.L. Enumeration of CD34+ cells in cord blood: a variation on a single-plantform flow cytometric method based on the ISHAGE gating strategy. Cytometry 2001; 46: 254-61.

[12]

Зуева E.E. Молчанова И.В., Комарова Л.С. и др. Особенности количественного определения гемопоэтических стволовых клеток методом проточной цитометрии. Молекулярная медицина 2006; В печати.

[13]

Laroche V., McKenna D.H., Moroff G. et al. Cell loss and recovery in umbilical cord processing: a comparison of postthaw and postwash samples. Transfusion 2005; 45:1909-16.

RIGHTS & PERMISSIONS

Eco-Vector

PDF

208

Accesses

0

Citation

Detail

Sections
Recommended

/